Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Dec;26(3):388–396.

Immune complexes and complement hypercatabolism in patients with leprosy.

B Bjorvatn, R S Barnetson, G Kronvall, R H Zubler, P H Lambert
PMCID: PMC1540968  PMID: 1009681

Abstract

The occurrence of immune complexes in the serum and the level of the C3 breakdown product C3d in the plasma from patients with leprosy were studied by quantitative methods and the results were compared in various forms of the disease. These studies were performed on sixty-two samples from twenty-six patients. The serum 125I-C1q binding activity was found to be increased by more than 2 s.d., as compared to the normal values, in most of the sera from patients with erythema nodosum leprosum (ENL) (80%) and uncomplicated lepromatous leprosy (82%), but also in the sera from patients with tuberculoid leprosy (58%). In vitro studies suggested that immune complexes involving mycobacterial antigens were present in leprosy sera. An increased C3d level (greater than 2s.d.) was also found in most of the plasma from patients with ENL (70%), but rarely in the plasma from patients with uncomplicated lepromatous leprosy (18%) and never in tuberculoid leprosy patients' plasma. The absence of a significant correlation between the 125I-C1q binding activity and the C3d level in leprosy patients may suggest that extravascular immune complexes are involved in the complement activation occurring in ENL. The quantitation of C3d in plasma may be of some practical interest in the early diagnosis of ENL complications of leprosy.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Winchester R. J., Kunkel H. G. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology. 1970 Dec;19(6):909–919. [PMC free article] [PubMed] [Google Scholar]
  2. Bonomo L., Dammacco F. Immune complex cryoglobulinaemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. Clin Exp Immunol. 1971 Aug;9(2):175–181. [PMC free article] [PubMed] [Google Scholar]
  3. Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
  4. Gelber R. H., Drutz D. J., Epstein W. V., Fasal P. Clinical correlates of C1Q-precipitating substances in the sera of patients with leprosy. Am J Trop Med Hyg. 1974 May;23(3):471–475. doi: 10.4269/ajtmh.1974.23.471. [DOI] [PubMed] [Google Scholar]
  5. Malaviya A. N., Pasricha A., Pasricha J. S., Mehta J. S. Significance of serologic abnormalities in lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1972 Oct-Dec;40(4):361–365. [PubMed] [Google Scholar]
  6. Moran C. J., Ryder G., Turk J. L., Waters M. F. Evidence for circulating immune complexes in lepromatous leprosy. Lancet. 1972 Sep 16;2(7777):572–573. doi: 10.1016/s0140-6736(72)91962-9. [DOI] [PubMed] [Google Scholar]
  7. Nydegger U. E., Achermann L. M., Lambert P. H., Miescher P. A. A simple automated method for complement estimation in a continuous flow system. J Immunol. 1972 Oct;109(4):910–913. [PubMed] [Google Scholar]
  8. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Perrin L. H., Lambert P. H., Miescher P. A. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest. 1975 Jul;56(1):165–176. doi: 10.1172/JCI108065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Perrin L. H., Lambert P. H., Miescher P. A. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis. Clin Exp Immunol. 1974 Apr;16(4):575–581. [PMC free article] [PubMed] [Google Scholar]
  11. Petchclai B., Chutanondh R., Prasongsom S., Hiranras S., Ramasoota T. Complement profile in leprosy. Am J Trop Med Hyg. 1973 Nov;22(6):761–764. doi: 10.4269/ajtmh.1973.22.761. [DOI] [PubMed] [Google Scholar]
  12. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  13. Rojas-Espinosa O., Mendez-Navarrete I., Estrada-Parra S. Presence of C1q-reactive immune complexes in patients with leprosy. Clin Exp Immunol. 1972 Oct;12(2):215–223. [PMC free article] [PubMed] [Google Scholar]
  14. Saitz E. W., Dierks R. E., Shepard C. C. Complement and the second component of complement in leprosy. Int J Lepr Other Mycobact Dis. 1968 Oct-Dec;36(4):400–404. [PubMed] [Google Scholar]
  15. Schur P. H., Austen K. F. Complement in human disease. Annu Rev Med. 1968;19:1–24. doi: 10.1146/annurev.me.19.020168.000245. [DOI] [PubMed] [Google Scholar]
  16. Shwe T. Immune complexes in glomeruli of patients with leprosy. Lepr Rev. 1971 Dec;42(4):282–289. doi: 10.5935/0305-7518.19710034. [DOI] [PubMed] [Google Scholar]
  17. WATERS M. F., RIDLEY D. S. NECROTIZING REACTIONS IN LEPROMATOUS LEPROSY. A CLINICAL AND HISTOLOGIC STUDY. Int J Lepr. 1963 Oct-Dec;31:418–436. [PubMed] [Google Scholar]
  18. Wemambu S. N., Turk J. L., Waters M. F., Rees R. J. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet. 1969 Nov 1;2(7627):933–935. doi: 10.1016/s0140-6736(69)90592-3. [DOI] [PubMed] [Google Scholar]
  19. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]
  20. Zubler R. H., Nydegger U., Perrin L. H., Fehr K., McCormick J., Lambert P. H., Miescher P. A. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest. 1976 May;57(5):1308–1319. doi: 10.1172/JCI108399. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES